Focus: Podimetrics is a pre-revenue medical device company specializing in diabetic foot ulcer detection through thermal monitoring technology (SmartMat). At 1–50 employees, it operates as an early-stage biotech focused on a high-prevalence chronic disease indication.
Profile data last refreshed 16m ago · AI intelligence enriched 2mo ago
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Best suited for early-stage commercialization, medical device, or mission-driven professionals willing to accept higher financial/stability risk for equity upside and hands-on impact.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Podimetrics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Podimetrics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo